acetylgalactosamine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pasca, S; Zanon, E | 1 |
1 other study(ies) available for acetylgalactosamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Light and shadows of the new therapies for haemophilia treatment in the COVID-19 era.
Topics: Acetylgalactosamine; Antibodies, Bispecific; Antibodies, Monoclonal, Humanized; COVID-19; Disease Management; Hemophilia A; Humans; RNA, Small Interfering | 2021 |